Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2005
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105722A1 Crystal comprising (2r)-2-propyloctoic acid and amine
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105130A1 Novel therapeutic usage of factor derived from pigment epithelium, capable of inhibiting nadph oxidase activity
11/10/2005WO2005105128A1 Methods of producing treated ganoderma lucidum product and processed ganoderma lucidum product
11/10/2005WO2005105113A2 Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine
11/10/2005WO2005105098A2 Preparation for the treatment of cancer
11/10/2005WO2005105086A1 Method for reducing gastrointestinal toxicity due to the administration of tegafur
11/10/2005WO2005105062A2 2-methylthiazolidine-2,4-dicarboxylic acid-containing combination preparations
11/10/2005WO2005002672A3 Sirt1 modulators for manipulating cells/organism lifespan/stress response
11/10/2005WO2004087121A8 Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
11/10/2005US20050251871 Novel ubiquitin ligases as therapeutic targets
11/10/2005US20050250939 Process for the production of multiple cross-linked hyaluronic acid derivatives
11/10/2005US20050250881 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250797 Quinzoline derivatives for use in the treatment of cancer
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250771 Substituted indoles and their use as integrin antagonists
11/10/2005US20050250749 Helix 12 directed pharmaceutical products
11/10/2005US20050250716 Immunostimulatory oligodeoxynucleotides
11/10/2005US20050250715 Remedy
11/10/2005US20050250698 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250697 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250693 Metalloproteinase inhibitors
11/10/2005US20050250689 Antagonists for human prolactin
11/10/2005US20050250679 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
11/10/2005US20050250672 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents
11/10/2005US20050250203 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050250167 Purified pkb ser 473 kinase and uses thereof
11/10/2005US20050250166 Cdc7-ask kinase complex, substrates of the kinase complex, antibody specific to the substrate, and method of screening compound capable of inhibiting cdc7-ask kinase using the same
11/10/2005US20050250162 Preventives/remedies for myeloma tumor and method of diagnosing the same
11/10/2005US20050250102 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
11/10/2005US20050249783 Method of improving absorption of vitamin e by a pet animal
11/10/2005US20050249756 Use of human prostate cell lines in cancer treatment
11/10/2005US20050249738 Immunotoxins directed against malignant cells
11/10/2005US20050249728 Anti-IGF-I receptor antibody
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines
11/10/2005US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005DE102004019662A1 Pharmaceutically active substance, useful for treating tumors e.g. skin cancers, comprises dendritic cells of e.g. spinal marrow (loaded with toxins of spiders of the family Pholcidae) cultivated in the presence of interleukin
11/10/2005DE102004018363A1 Medicament, useful for the treatment of e.g. cancer and AIDS, comprises components and/or extracts of e.g. Prunus armenica, Cocos nucifera, Humulus lupulus, germinated barley/rye/wheat and Myceten as active agents
11/10/2005DE10112926B4 Verwendung von Aminooxyacetat zur Tumorbehandlung Use of aminooxyacetate for tumor treatment
11/10/2005DE10006033B4 Immunisierung eines Individuums gegen Carcinome und ihre Vorstufen Immunizing an individual against carcinomas and their precursors
11/10/2005CA2565832A1 Preparation for the treatment cancer
11/10/2005CA2565037A1 Purine derivatives as a1 adenosine receptor antagonists
11/10/2005CA2565013A1 Method for producing pentacyclic taxans
11/10/2005CA2564603A1 Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
11/10/2005CA2564249A1 Indole and azaindole derivatives with antitumor action
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2563982A1 Thienopyridines as ikk inhibitors
11/10/2005CA2563918A1 2-methylthiazolidine-2,4-dicarboxylic acid containing combination preparations
11/10/2005CA2563558A1 Sulfonamides
11/10/2005CA2555718A1 Naphthalimide derivatives for the treatment of cancer
11/09/2005EP1593691A1 Method of acquiring human monoclonal antibody inhibiting cancer cell proliferation
11/09/2005EP1593686A1 Antineoplastic peptides
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1593091A2 High contrast optoacoustical imaging using nanoparticles
11/09/2005EP1592795A2 Oligomeric compounds for the modulation of ras expression
11/09/2005EP1592793A2 Oligomeric compounds for the modulation of survivin expression
11/09/2005EP1592780A2 Dyrks as modifiers of the apc and axin pathways and methods of use
11/09/2005EP1592713A2 Antibodies to c-met for the treatment of cancers
11/09/2005EP1592697A1 Nucleoside analogues with apoptosis-inducing characteristics for treating diseases caused by rapidly proliferating cells
11/09/2005EP1592665A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
11/09/2005EP1592457A2 Vitamin receptor binding drug delivery conjugates
11/09/2005EP1592454A1 Tarp promoter and uses thereof
11/09/2005EP1592449A2 Sensitizing cells for apoptosis by selectively blocking cytokines
11/09/2005EP1592447A1 Devices and compositions containing boron and silicon for use in neutron capture therapy
11/09/2005EP1592441A2 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
11/09/2005EP1592431A1 Method of modulating il-6
11/09/2005EP1592423A2 Combination therapy of zd6474 with 5-fu and/or cpt-11
11/09/2005EP1592421A1 Heteroarylalkanoic acids as integrin receptor antagonists
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1480983B1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
11/09/2005EP1480981B1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1390369B1 4-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives
11/09/2005EP1368025B1 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
11/09/2005EP1353931B1 Transition metal complexes with proton sponges as ligands
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1261693B1 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1220932B1 Human carboxypeptidases and polynucleotides encoding the same
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1165576B1 Process for preparing amine platinum complexes
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1111048B1 Neutral amino acid transporter and gene thereof
11/09/2005EP1100788B1 Substituted quinazoline derivatives
11/09/2005EP1075519B1 Inhibitors of nf-kb activation
11/09/2005EP1066266B1 Cyclin dependent kinase inhibitors
1 ... 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 ... 2211